A paperfluidic platform to detect Neisseria gonorrhoeae in clinical samples

Audrey L. Horst, Justin M. Rosenbohm, Nikunja Kolluri, Justin Hardick, Charlotte A Gaydos, Mario Cabodi, Catherine M. Klapperich, Jacqueline C. Linnes

Research output: Contribution to journalArticle

Abstract

Globally, the microbe Neisseria gonorrhoeae (NG) causes 106 million newly documented sexually transmitted infections each year. Once appropriately diagnosed, NG infections can be readily treated with antibiotics, but high-risk patients often do not return to the clinic for treatment if results are not provided at the point of care. A rapid, sensitive molecular diagnostic would help increase NG treatment and reduce the prevalence of this sexually transmitted disease. Here, we report on the design and development of a rapid, highly sensitive, paperfluidic device for point-of-care diagnosis of NG. The device integrates patient swab sample lysis, nucleic acid extraction, thermophilic helicase-dependent amplification (tHDA), an internal amplification control (NGIC), and visual lateral flow detection within an 80 min run time. Limits of NG detection for the NG/NGIC multiplex tHDA assay were determined within the device, and clinical performance was validated retroactively against qPCR-quantified patient samples in a proof-of-concept study. This paperfluidic diagnostic has a clinically relevant limit of detection of 500 NG cells per device with analytical sensitivity down to 10 NG cells per device. In triplicate testing of 40 total urethral and vaginal swab samples, the device had 95% overall sensitivity and 100% specificity, approaching current laboratory-based molecular NG diagnostics. This diagnostic platform could increase access to accurate NG diagnoses to those most in need.

Original languageEnglish (US)
Article number35
JournalBiomedical Microdevices
Volume20
Issue number2
DOIs
StatePublished - Jun 1 2018

Fingerprint

Neisseria gonorrhoeae
Amplification
Equipment and Supplies
Nucleic acids
Antibiotics
Point-of-Care Systems
Assays
Sexually Transmitted Diseases
Testing
Molecular Pathology
Nucleic Acids
Limit of Detection
Anti-Bacterial Agents
Sensitivity and Specificity

Keywords

  • internal amplification control
  • isothermal amplification
  • molecular diagnostic
  • Neisseria gonorrhoeae
  • paperfluidic
  • point of care
  • thermophilic helicase dependent amplification
  • urethral swab
  • vaginal swab

ASJC Scopus subject areas

  • Biomedical Engineering
  • Molecular Biology

Cite this

Horst, A. L., Rosenbohm, J. M., Kolluri, N., Hardick, J., Gaydos, C. A., Cabodi, M., ... Linnes, J. C. (2018). A paperfluidic platform to detect Neisseria gonorrhoeae in clinical samples. Biomedical Microdevices, 20(2), [35]. https://doi.org/10.1007/s10544-018-0280-x

A paperfluidic platform to detect Neisseria gonorrhoeae in clinical samples. / Horst, Audrey L.; Rosenbohm, Justin M.; Kolluri, Nikunja; Hardick, Justin; Gaydos, Charlotte A; Cabodi, Mario; Klapperich, Catherine M.; Linnes, Jacqueline C.

In: Biomedical Microdevices, Vol. 20, No. 2, 35, 01.06.2018.

Research output: Contribution to journalArticle

Horst, AL, Rosenbohm, JM, Kolluri, N, Hardick, J, Gaydos, CA, Cabodi, M, Klapperich, CM & Linnes, JC 2018, 'A paperfluidic platform to detect Neisseria gonorrhoeae in clinical samples', Biomedical Microdevices, vol. 20, no. 2, 35. https://doi.org/10.1007/s10544-018-0280-x
Horst, Audrey L. ; Rosenbohm, Justin M. ; Kolluri, Nikunja ; Hardick, Justin ; Gaydos, Charlotte A ; Cabodi, Mario ; Klapperich, Catherine M. ; Linnes, Jacqueline C. / A paperfluidic platform to detect Neisseria gonorrhoeae in clinical samples. In: Biomedical Microdevices. 2018 ; Vol. 20, No. 2.
@article{c046c46144d44e118365df76c3015577,
title = "A paperfluidic platform to detect Neisseria gonorrhoeae in clinical samples",
abstract = "Globally, the microbe Neisseria gonorrhoeae (NG) causes 106 million newly documented sexually transmitted infections each year. Once appropriately diagnosed, NG infections can be readily treated with antibiotics, but high-risk patients often do not return to the clinic for treatment if results are not provided at the point of care. A rapid, sensitive molecular diagnostic would help increase NG treatment and reduce the prevalence of this sexually transmitted disease. Here, we report on the design and development of a rapid, highly sensitive, paperfluidic device for point-of-care diagnosis of NG. The device integrates patient swab sample lysis, nucleic acid extraction, thermophilic helicase-dependent amplification (tHDA), an internal amplification control (NGIC), and visual lateral flow detection within an 80 min run time. Limits of NG detection for the NG/NGIC multiplex tHDA assay were determined within the device, and clinical performance was validated retroactively against qPCR-quantified patient samples in a proof-of-concept study. This paperfluidic diagnostic has a clinically relevant limit of detection of 500 NG cells per device with analytical sensitivity down to 10 NG cells per device. In triplicate testing of 40 total urethral and vaginal swab samples, the device had 95{\%} overall sensitivity and 100{\%} specificity, approaching current laboratory-based molecular NG diagnostics. This diagnostic platform could increase access to accurate NG diagnoses to those most in need.",
keywords = "internal amplification control, isothermal amplification, molecular diagnostic, Neisseria gonorrhoeae, paperfluidic, point of care, thermophilic helicase dependent amplification, urethral swab, vaginal swab",
author = "Horst, {Audrey L.} and Rosenbohm, {Justin M.} and Nikunja Kolluri and Justin Hardick and Gaydos, {Charlotte A} and Mario Cabodi and Klapperich, {Catherine M.} and Linnes, {Jacqueline C.}",
year = "2018",
month = "6",
day = "1",
doi = "10.1007/s10544-018-0280-x",
language = "English (US)",
volume = "20",
journal = "Biomedical Microdevices",
issn = "1387-2176",
publisher = "Kluwer Academic Publishers",
number = "2",

}

TY - JOUR

T1 - A paperfluidic platform to detect Neisseria gonorrhoeae in clinical samples

AU - Horst, Audrey L.

AU - Rosenbohm, Justin M.

AU - Kolluri, Nikunja

AU - Hardick, Justin

AU - Gaydos, Charlotte A

AU - Cabodi, Mario

AU - Klapperich, Catherine M.

AU - Linnes, Jacqueline C.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Globally, the microbe Neisseria gonorrhoeae (NG) causes 106 million newly documented sexually transmitted infections each year. Once appropriately diagnosed, NG infections can be readily treated with antibiotics, but high-risk patients often do not return to the clinic for treatment if results are not provided at the point of care. A rapid, sensitive molecular diagnostic would help increase NG treatment and reduce the prevalence of this sexually transmitted disease. Here, we report on the design and development of a rapid, highly sensitive, paperfluidic device for point-of-care diagnosis of NG. The device integrates patient swab sample lysis, nucleic acid extraction, thermophilic helicase-dependent amplification (tHDA), an internal amplification control (NGIC), and visual lateral flow detection within an 80 min run time. Limits of NG detection for the NG/NGIC multiplex tHDA assay were determined within the device, and clinical performance was validated retroactively against qPCR-quantified patient samples in a proof-of-concept study. This paperfluidic diagnostic has a clinically relevant limit of detection of 500 NG cells per device with analytical sensitivity down to 10 NG cells per device. In triplicate testing of 40 total urethral and vaginal swab samples, the device had 95% overall sensitivity and 100% specificity, approaching current laboratory-based molecular NG diagnostics. This diagnostic platform could increase access to accurate NG diagnoses to those most in need.

AB - Globally, the microbe Neisseria gonorrhoeae (NG) causes 106 million newly documented sexually transmitted infections each year. Once appropriately diagnosed, NG infections can be readily treated with antibiotics, but high-risk patients often do not return to the clinic for treatment if results are not provided at the point of care. A rapid, sensitive molecular diagnostic would help increase NG treatment and reduce the prevalence of this sexually transmitted disease. Here, we report on the design and development of a rapid, highly sensitive, paperfluidic device for point-of-care diagnosis of NG. The device integrates patient swab sample lysis, nucleic acid extraction, thermophilic helicase-dependent amplification (tHDA), an internal amplification control (NGIC), and visual lateral flow detection within an 80 min run time. Limits of NG detection for the NG/NGIC multiplex tHDA assay were determined within the device, and clinical performance was validated retroactively against qPCR-quantified patient samples in a proof-of-concept study. This paperfluidic diagnostic has a clinically relevant limit of detection of 500 NG cells per device with analytical sensitivity down to 10 NG cells per device. In triplicate testing of 40 total urethral and vaginal swab samples, the device had 95% overall sensitivity and 100% specificity, approaching current laboratory-based molecular NG diagnostics. This diagnostic platform could increase access to accurate NG diagnoses to those most in need.

KW - internal amplification control

KW - isothermal amplification

KW - molecular diagnostic

KW - Neisseria gonorrhoeae

KW - paperfluidic

KW - point of care

KW - thermophilic helicase dependent amplification

KW - urethral swab

KW - vaginal swab

UR - http://www.scopus.com/inward/record.url?scp=85045283796&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045283796&partnerID=8YFLogxK

U2 - 10.1007/s10544-018-0280-x

DO - 10.1007/s10544-018-0280-x

M3 - Article

VL - 20

JO - Biomedical Microdevices

JF - Biomedical Microdevices

SN - 1387-2176

IS - 2

M1 - 35

ER -